drugset
drugset / Trial / NCT06043739

Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects

NCT06043739 ↗

Phase 1 Completed 12 enrolled Lakefront Biotherapeutics NV
RandomizedCrossoverOpen-labelBasic science

Summary

Open label study to assess relative bioavailability of filgotinib oral mini-tablet versus oral tablet formulation and effect of food on the mini-tablet formulation.

Timeline

Start
2023-09-22
Primary completion
2023-10-27
Completion
2023-11-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Filgotinib Small molecule — Oral

Indications

No indication recorded.